PROGYNY INC (PGNY) Stock Fundamental Analysis
USA - NASDAQ:PGNY - US74340E1038 - Common Stock
23.53 USD
-0.09 (-0.38%)
Overall PGNY gets a fundamental rating of 7 out of 10. We evaluated PGNY against 100 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making PGNY a very profitable company, without any liquidiy or solvency issues. PGNY is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make PGNY a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
In the past year PGNY was profitable.
In the past year PGNY had a positive cash flow from operations.
In the past 5 years PGNY has always been profitable.
In the past 5 years PGNY always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of PGNY (7.11%) is better than 88.00% of its industry peers.
The Return On Equity of PGNY (10.10%) is better than 73.00% of its industry peers.
PGNY has a Return On Invested Capital of 11.24%. This is amongst the best in the industry. PGNY outperforms 84.00% of its industry peers.
PGNY had an Average Return On Invested Capital over the past 3 years of 8.25%. This is in line with the industry average of 9.45%.
The last Return On Invested Capital (11.24%) for PGNY is above the 3 year average (8.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROIC | 11.24% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
1.3 Margins
PGNY's Profit Margin of 4.46% is fine compared to the rest of the industry. PGNY outperforms 76.00% of its industry peers.
PGNY's Profit Margin has declined in the last couple of years.
The Operating Margin of PGNY (6.77%) is better than 67.00% of its industry peers.
PGNY's Operating Margin has improved in the last couple of years.
The Gross Margin of PGNY (22.94%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of PGNY has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% |
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
2. Health
2.1 Basic Checks
PGNY has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
PGNY has less shares outstanding than it did 1 year ago.
The number of shares outstanding for PGNY has been increased compared to 5 years ago.
There is no outstanding debt for PGNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 8.09 indicates that PGNY is not in any danger for bankruptcy at the moment.
The Altman-Z score of PGNY (8.09) is better than 93.00% of its industry peers.
PGNY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.09 |
ROIC/WACC1.23
WACC9.11%
2.3 Liquidity
PGNY has a Current Ratio of 2.96. This indicates that PGNY is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PGNY (2.96) is better than 85.00% of its industry peers.
A Quick Ratio of 2.96 indicates that PGNY has no problem at all paying its short term obligations.
PGNY's Quick ratio of 2.96 is amongst the best of the industry. PGNY outperforms 85.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 8.62% over the past year.
Measured over the past years, PGNY shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.77% on average per year.
The Revenue has grown by 11.41% in the past year. This is quite good.
PGNY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 38.42% yearly.
EPS 1Y (TTM)8.62%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%36.36%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.32%
3.2 Future
PGNY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.47% yearly.
PGNY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.86% yearly.
EPS Next Y10.72%
EPS Next 2Y34.66%
EPS Next 3Y31.82%
EPS Next 5Y32.47%
Revenue Next Year9.74%
Revenue Next 2Y9.58%
Revenue Next 3Y10.09%
Revenue Next 5Y8.86%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 37.35, which means the current valuation is very expensive for PGNY.
Compared to the rest of the industry, the Price/Earnings ratio of PGNY is on the same level as its industry peers.
When comparing the Price/Earnings ratio of PGNY to the average of the S&P500 Index (26.28), we can say PGNY is valued slightly more expensively.
Based on the Price/Forward Earnings ratio of 22.77, the valuation of PGNY can be described as rather expensive.
PGNY's Price/Forward Earnings is on the same level as the industry average.
PGNY's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 33.61.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.35 | ||
| Fwd PE | 22.77 |
4.2 Price Multiples
PGNY's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, PGNY is valued cheaply inside the industry as 85.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.46 | ||
| EV/EBITDA | 16.33 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PGNY does not grow enough to justify the current Price/Earnings ratio.
PGNY has a very decent profitability rating, which may justify a higher PE ratio.
PGNY's earnings are expected to grow with 31.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.48
PEG (5Y)N/A
EPS Next 2Y34.66%
EPS Next 3Y31.82%
5. Dividend
5.1 Amount
PGNY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:PGNY (11/11/2025, 9:42:04 AM)
23.53
-0.09 (-0.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.25%
Inst Owner Change3.8%
Ins Owners1.34%
Ins Owner Change0.04%
Market Cap2.02B
Revenue(TTM)1.27B
Net Income(TTM)56.57M
Analysts80
Price Target29.29 (24.48%)
Short Float %8.26%
Short Ratio5.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.43%
Min EPS beat(2)14.22%
Max EPS beat(2)14.63%
EPS beat(4)3
Avg EPS beat(4)8.02%
Min EPS beat(4)-11.77%
Max EPS beat(4)15%
EPS beat(8)5
Avg EPS beat(8)7.07%
EPS beat(12)9
Avg EPS beat(12)35.08%
EPS beat(16)13
Avg EPS beat(16)94.29%
Revenue beat(2)2
Avg Revenue beat(2)2.31%
Min Revenue beat(2)1.96%
Max Revenue beat(2)2.66%
Revenue beat(4)4
Avg Revenue beat(4)3.39%
Min Revenue beat(4)1.96%
Max Revenue beat(4)5.74%
Revenue beat(8)4
Avg Revenue beat(8)-0.43%
Revenue beat(12)7
Avg Revenue beat(12)0.39%
Revenue beat(16)9
Avg Revenue beat(16)-0.09%
PT rev (1m)0%
PT rev (3m)5.24%
EPS NQ rev (1m)-0.91%
EPS NQ rev (3m)22.47%
EPS NY rev (1m)0%
EPS NY rev (3m)13.07%
Revenue NQ rev (1m)0.36%
Revenue NQ rev (3m)3.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.35 | ||
| Fwd PE | 22.77 | ||
| P/S | 1.59 | ||
| P/FCF | 10.46 | ||
| P/OCF | 9.72 | ||
| P/B | 3.61 | ||
| P/tB | 3.79 | ||
| EV/EBITDA | 16.33 |
EPS(TTM)0.63
EY2.68%
EPS(NY)1.03
Fwd EY4.39%
FCF(TTM)2.25
FCFY9.56%
OCF(TTM)2.42
OCFY10.29%
SpS14.76
BVpS6.51
TBVpS6.21
PEG (NY)3.48
PEG (5Y)N/A
Graham Number9.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROCE | 14.68% | ||
| ROIC | 11.24% | ||
| ROICexc | 27.43% | ||
| ROICexgc | 30.82% | ||
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% | ||
| FCFM | 15.25% |
ROA(3y)7.58%
ROA(5y)11.89%
ROE(3y)10.72%
ROE(5y)17.23%
ROIC(3y)8.25%
ROIC(5y)7.66%
ROICexc(3y)19.18%
ROICexc(5y)17.15%
ROICexgc(3y)20.6%
ROICexgc(5y)18.86%
ROCE(3y)10.79%
ROCE(5y)10.01%
ROICexgc growth 3Y11.16%
ROICexgc growth 5Y-10.91%
ROICexc growth 3Y11.54%
ROICexc growth 5Y-2.19%
OM growth 3Y-3.61%
OM growth 5Y1.87%
PM growth 3Y-29.25%
PM growth 5YN/A
GM growth 3Y-1.03%
GM growth 5Y1.85%
F-Score7
Asset Turnover1.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 330.21% | ||
| Cap/Sales | 1.16% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 230.54% | ||
| Profit Quality | 342.01% | ||
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 | ||
| Altman-Z | 8.09 |
F-Score7
WACC9.11%
ROIC/WACC1.23
Cap/Depr(3y)177.5%
Cap/Depr(5y)150.16%
Cap/Sales(3y)0.4%
Cap/Sales(5y)0.39%
Profit Quality(3y)290.66%
Profit Quality(5y)196.79%
High Growth Momentum
Growth
EPS 1Y (TTM)8.62%
EPS 3Y-4.77%
EPS 5YN/A
EPS Q2Q%36.36%
EPS Next Y10.72%
EPS Next 2Y34.66%
EPS Next 3Y31.82%
EPS Next 5Y32.47%
Revenue 1Y (TTM)11.41%
Revenue growth 3Y32.6%
Revenue growth 5Y38.42%
Sales Q2Q%9.32%
Revenue Next Year9.74%
Revenue Next 2Y9.58%
Revenue Next 3Y10.09%
Revenue Next 5Y8.86%
EBIT growth 1Y31.12%
EBIT growth 3Y27.82%
EBIT growth 5Y41.01%
EBIT Next Year33.19%
EBIT Next 3Y18.12%
EBIT Next 5Y15.38%
FCF growth 1Y-2.78%
FCF growth 3Y93.67%
FCF growth 5YN/A
OCF growth 1Y2.69%
OCF growth 3Y90.18%
OCF growth 5YN/A
PROGYNY INC / PGNY FAQ
What is the fundamental rating for PGNY stock?
ChartMill assigns a fundamental rating of 7 / 10 to PGNY.
What is the valuation status for PGNY stock?
ChartMill assigns a valuation rating of 4 / 10 to PROGYNY INC (PGNY). This can be considered as Fairly Valued.
How profitable is PROGYNY INC (PGNY) stock?
PROGYNY INC (PGNY) has a profitability rating of 7 / 10.
What are the PE and PB ratios of PROGYNY INC (PGNY) stock?
The Price/Earnings (PE) ratio for PROGYNY INC (PGNY) is 37.35 and the Price/Book (PB) ratio is 3.61.
Can you provide the expected EPS growth for PGNY stock?
The Earnings per Share (EPS) of PROGYNY INC (PGNY) is expected to grow by 10.72% in the next year.